Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03455582

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

Longitudinal Study of Cognition in Primary Progressive Multiple Sclerosis: a Cohort Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Cognitive impairment is nowadays more and more recognized as an important feature of the multiple sclerosis (MS) disease. Cognitive disorders frequency in MS is estimated between 40 and 60%. Cognitive impairment affects quality of life and vocational status in MS patients. Until recently, little information was available on the cognitive dysfunction and their evolution that occur in primary progressive multiple sclerosis (PPMS) as compared with relapsing-remitting MS (RRMS). In PPMS pathological studies have shown the importance of cortical demyelination and meningeal inflammation suggesting that the GM alteration could play a major role in the cognitive impairment in this phenotype. The cognitive evolution and the brain tissue alteration at the origin of these difficulties remain poorly understood in PPMS. The use of new techniques for morphological and functional MRI can study the contribution of diffuse White Matter (WM) alteration (probably through disconnexion of relevant network) and diffuse Grey matter (GM) alterations in the cerebral cortex and other structures (the hippocampi, the cerebellum, and the thalami) in cognitive impairment in PPMS patients and on their evolution.

Conditions

Interventions

TypeNameDescription
OTHERClinical assessmentExpanded Disability Status Scale (EDSS), ambulation test and Multiple Sclerosis functional composite (MSFC). Medications will be recorded.
OTHEREcological evaluationVirtual reality task and Actual reality
OTHERNeuropsychological evaluationcognitive tests exploring information processing speed, attention/concentration, working and episodic memories and executive function
OTHERPsychological evaluationquestionnaires for depression, anxiety and fatigue
DEVICEMRI Evaluationmorphological MRI and resting state functional MRI (fMRI)

Timeline

Start date
2018-09-24
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2018-03-06
Last updated
2026-02-03

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03455582. Inclusion in this directory is not an endorsement.